Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023 Announces cost...

Related Keywords

Bedford ,Massachusetts ,United States ,Boston ,Piper Sandler ,Cherylr Blanchard ,Mark Namaroff ,Anika Therapeutics Inc ,Globenewswire Inc ,Nasdaq ,Corporate Communications ,Exchange Commission ,Regenerative Solutions ,Securities Exchange ,Arthrosurface Joint Solutions ,Anika Therapeutics ,Sports Medicine ,Integrity Implant System ,Recent Business Highlights ,Leadership Position ,Highly Differentiated Portfolio ,Based Regenerative ,Implant System ,Key Products ,Arthrosurface Joint ,Biocomposite Fixation System ,Reverse Shoulder Arthroplasty System ,Investor Relations ,Osteoarthritis Pain Management ,Net Income ,Securities Act ,Securities Exchange Act ,Cost Reductions ,Investor Inquiries ,Three Months Ended ,Twelve Months Ended ,Adjusted Gross Profit ,Adjusted Net ,Earnings Per Share ,Adjusted Diluted Earnings Per ,